What is Citius Oncology, Inc.'s intangible purchases?

Citius Oncology, Inc. (CTOR) reported intangible purchases of $600K in Q1 2026.

How has Citius Oncology, Inc.'s intangible purchases changed year-over-year?

Citius Oncology, Inc.'s intangible purchases decreased by 58.3% year-over-year, from $1.44M to $600K.

What does intangible purchases mean?

Cash spent acquiring intangible assets such as patents, licenses, and other intellectual property.

Citius Oncology, Inc. CTOR Intangible Purchases

Intangible Purchases at other companies

Aebi Schmidt Holding AG Common StockAEBI

$0-100%

Mesa LaboratoriesMLAB

$0-100%

ShutterstockSSTK

$191K-78.7%

PennyMac Financial Services, Inc.PFSI

$15.93M+123%

SOL

SOLSSOLS

$4M—

ADTADT

$102.25M-4.4%

Other financials

Income statement

See full

Revenue$1.7M—

Gross profit$1.3M—

Operating income-$28.6M-283%

Net income-$26.6M-244%

EPS (diluted)-$0.27-145%

Balance sheet

See full

Cash & equivalents$2.6M+2,350,466%

Total equity$35.3M-1.0%

Total assets$100.7M+10.1%

Cash flow

See full

Operating cash flow-$3.8M-179%

Valuation

See full

Market cap$60.45M-74.7%

Returns & leverage

See full

Return on equity-119.9%+46.7pp

Current ratio0.5×+0.1×

Where this comes from

Reported directly by Citius Oncology, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireIntangibleAssets.

The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Citius Oncology, Inc.'s intangible purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Citius Oncology, Inc.'s intangible purchases?: Citius Oncology, Inc. (CTOR) reported intangible purchases of $600K in Q1 2026.
How has Citius Oncology, Inc.'s intangible purchases changed year-over-year?: Citius Oncology, Inc.'s intangible purchases decreased by 58.3% year-over-year, from $1.44M to $600K.
What does intangible purchases mean?: Cash spent acquiring intangible assets such as patents, licenses, and other intellectual property.